Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmatrans SANAQ is a Swiss pharmaceutical company that specializes in the development, production, and distribution of innovative excipients and active pharmaceutical ingredients (APIs). Founded in 1982, the company offers a wide range of specialized products under the SANAQ brand, focusing on oral solid dosage forms and drug delivery systems. Their expertise lies in co-processed excipients for direct compression, which help pharmaceutical manufacturers optimize production efficiency and drug stability. In addition to product supply, Pharmatrans SANAQ provides technical support and formulation services to help clients overcome complex manufacturing challenges. The company serves a global market, providing solutions for both the pharmaceutical and nutraceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmatrans SANAQ.